Open · RFA-DK-27-147 · CFDA 93.847 · Discretionary

Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

up to $2.2M
Award range
Open
Status
48d
Days left
1
Expected awards

The verdict

Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed) is an open discretionary opportunity from National Institutes of Health, offering Up to $2,200,000 across 1 expected award. Applications close in 48 days.

up to $2.2M
award range
Open
48 days left
1
expected award
93.847
CFDA program

Opportunity snapshot. This Grants.gov announcement - Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed) - is cataloged under number RFA-DK-27-147 and tied to CFDA assistance listing 93.847, posted by National Institutes of Health. Grants.gov currently shows the opportunity as open, first posted on May 20, 2026. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is Up to $2,200,000. The agency has projected $3.3 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $3.3 million estimated pool, the average award works out to roughly $3.3 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. Applications close on September 30, 2026 - roughly 48 days from today. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Up to $2,200,000

Close Date

September 30, 2026

Posted

May 20, 2026

Est. Total Funding

$3,300,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

This is a NOFO for a Single Source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is announcing its intent to issue a single source cooperative agreement award to Beckman Research Institute/City of Hope for the currently funded Integrated Islet Distribution Program (IIDP) to renew the program and maintain support for its continuing mission to provide the scientific community with important islet resources for diabetes research. The IIDP facilitates the distribution of human islets to biomedical researchers by establishing partnerships with qualified islet isolation facilities to prepare and distribute human islets. Human islets remain an essential resource for diabetes research to advance our understanding of human islet cell biology, and to promote the development of new therapies for the prevention and treatment of diabetes.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.

Eligibility

Grants.gov lists this opportunity under eligibility category code 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Division of Diabetes, Endocrinology and Metabolic Diseases NIDDK_DEM@nih.gov

Key Dates

Posted May 20, 2026
Close Date September 30, 2026
Archive Date November 29, 2026
Last Updated May 20, 2026

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)", offered by National Institutes of Health. It is associated with CFDA program 93.847. This is a NOFO for a Single Source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH...
Is this opportunity still open?
Yes, this opportunity is currently open for applications. The closing date is September 30, 2026.
How much funding is available?
The award range for this opportunity is Up to $2,200,000. Total estimated funding: $3,300,000. Expected number of awards: 1.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants